Reporting Manager
Simeon George
Symbol
DSGN
Shares outstanding
61,756,000 shares
Disclosed Ownership
6,607,892 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
11 Mar 2026, 21:28:31 UTC
Date of event
09 Mar 2026

Sponsored

Quoteable Key Fact

"SR One Capital Fund I Aggregator LP disclosed 11% ownership in Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN) on 09 Mar 2026."

Quick Takeaways

  • SR One Capital Fund I Aggregator LP filed SCHEDULE 13D/A for Design Therapeutics, Inc. Common Stock, $0.0001 par value per share (DSGN).
  • Disclosed ownership: 11%.
  • Date of event: 09 Mar 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Mar 2026, 21:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SR One Capital Fund I Aggregator, LP 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member 0001848319
SR One Capital Partners I, LP 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
SR One Capital Management, LLC 11% 6,526,476 0 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member
Simeon George 11% 6,607,892 81,416 6,526,476 /s/ Sasha Keough Sasha Keough, as attorney-in-fact for Simeon George, M.D., Managing Member